GI & Endoscopy

Medical device company EvoEndo has been cleared by the FDA to market and sell its EvoEndo single-use endoscopy system.

The gastroenterology sector continued to experience rapid consolidation in the fourth quarter in 2021, according to a market update from Provident.

Gastroenterology management companies Gastro Health, GI Alliance and United Digestive made big moves in 2021, accelerating the consolidation of the industry. 

Vivek Kaul, MD, a gastroenterologist at University of Rochester (N.Y.) Medical Center and Strong Memorial Hospital, joined Becker's ASC Review to discuss the forces deciding the future of healthcare and how ASCs can thrive in a competitive market. 

As the COVID-19 pandemic demanded all hands on deck in the medical community, and patients put off preventive care, many other medical services fell by the wayside. The resulting ripple effects may be felt for years to come.

A new model could help determine a patient's most effective treatment option for gastric cancer.

The FDA granted Motus GI market clearance for its second-generation Pure-Vu EVS system.

The lowering of the colorectal cancer screening age and the acceleration of the outpatient migration leaves gastroenterology ASCs and endoscopy centers primed for growth. 

Oral microbiome therapy SER-109 could be helpful in fighting recurrent Clostridioides difficile, which causes diarrhea and colitis, according to a study published Jan. 20 in The New England Journal of Medicine.

Acquisition of gastroenterology practices by management service organizations accelerated in 2021, with powerhouses like Miami-based Gastro Health and Southlake, Texas-based GI Alliance expanding their reach nationwide.